Atlas Trials

P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma

Clinical trial NCT04233840 · UNKNOWN

Trial details

NCT number
NCT04233840
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-02-12
Primary completion
2022-12-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.